PacBio (NASDAQ: PACB) has announced the appointment of Chris Smith to its board of directors, effective immediately. Chris ...

This news is based on a press release statement from PacBio. The company's products are intended for research purposes only ...

"We are thrilled to welcome Chris to the PacBio Board,” said Christian Henry, President and Chief Executive Officer of PacBio. "Mr. Smith’s deep expertise in clinical diagnostics and genomics, ...

Discover the top genomics startups revolutionizing genome sequencing technologies to enhance disease prevention and treatment ...

Key Findings Enabled by PacBio Technology: Synchronized Multiomic Sequencing: For the first time, a single sequencing run ...

The global organ transplant diagnostics market size was valued at USD 4.95 billion in 2024 and is projected to reach from USD ...

Many materials store information about what has happened to them in a sort of material memory, like wrinkles on a once ...

Strong government Investments and Precision medicine Propel Growth in Sanger Sequencing Market, Expected to Quadruple Its Size Over the Next Decade Akash Anand SNS Insider Pvt. Ltd 415-230-0044 email ...

One in every 10 people worldwide is impacted by a rare genetic disease but about 50% of them remain undiagnosed despite rapid ...

Long read sequencing revealed more genetic information in cases of 42 patients with rare diseases while cutting time and cost of diagnoses.

UC Santa Cruz researchers showcase how long-read sequencing can diagnose rare genetic diseases in days instead of years.

One in every 10 people worldwide is impacted by a rare genetic disease but about 50% of them remain undiagnosed despite rapid increases in genetic technology and testing.